Literature DB >> 8930983

1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor.

P Naveilhan1, I Neveu, D Wion, P Brachet.   

Abstract

Glial cell line-derived neurotrophic factor (GDNF) has significant therapeutic potentials, in particular for neurodegenerative disorders. To determine factors that would enhance GDNF expression, we analysed the effect of 1,25-(OH)2 D3 in C6 glioma cells. Treatment of C6 cells with 10(-7) M, 1,25-(OH)2 D3 for 48 h elicited an 18.5-fold increase in the level of GDNF mRNA. In addition, our results indicate that 1,25-(OH)2 D3 is effective at concentrations as low as 10(-10) M and that retinoic acid has additive effects. These data indicate that 1,25-(OH)2 D3 is a potent inducer of GDNF expression and suggest that 1,25-(OH)2 D3 may contribute to the regulation of GDNF in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930983     DOI: 10.1097/00001756-199609020-00023

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  60 in total

1.  Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.

Authors:  L D Brewer; V Thibault; K C Chen; M C Langub; P W Landfield; N M Porter
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Authors:  Robyn Balden; Amutha Selvamani; Farida Sohrabji
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

3.  Evoked dopamine overflow is augmented in the striatum of calcitriol treated rats.

Authors:  Wayne A Cass; Laura E Peters; Anita M Fletcher; David M Yurek
Journal:  Neurochem Int       Date:  2011-11-22       Impact factor: 3.921

Review 4.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

5.  Dietary vitamin D3 supplementation at 10× the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2012-05-17       Impact factor: 5.243

6.  Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine.

Authors:  Michael P Smith; Anita Fletcher-Turner; David M Yurek; Wayne A Cass
Journal:  Neurochem Res       Date:  2006-04       Impact factor: 3.996

7.  Association of serum 25-hydroxyvitamin D with symptoms of depression after 6 months in stroke patients.

Authors:  Wei Yue; Lei Xiang; Ya-Jing Zhang; Yong Ji; Xin Li
Journal:  Neurochem Res       Date:  2014-08-26       Impact factor: 3.996

Review 8.  From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D + all-trans retinoic acid + Temozolomide combination in treatment of GBM.

Authors:  Ilhan Elmaci; Aysel Ozpinar; Alp Ozpinar; Jennifer L Perez; Meric A Altinoz
Journal:  Metab Brain Dis       Date:  2019-04-01       Impact factor: 3.584

9.  Calcitriol promotes augmented dopamine release in the lesioned striatum of 6-hydroxydopamine treated rats.

Authors:  Wayne A Cass; Laura E Peters; Anita M Fletcher; David M Yurek
Journal:  Neurochem Res       Date:  2014-05-25       Impact factor: 3.996

10.  The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.

Authors:  Marie-France Nissou; Jacques Brocard; Michèle El Atifi; Audrey Guttin; Annie Andrieux; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.